(Q36201870)

12 August 2017

1 reference

title

The restless legs syndrome. (English)

1 reference

12 August 2017

restless legs syndrome

0 references

1

Claudia Trenkwalder

0 references

Walter Paulus

series ordinal

2

object named as

Walter Paulus

1 reference

12 August 2017

Arthur S Walters

3

1 reference

12 August 2017

1 August 2005

1 reference

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

8

1 reference

12 August 2017

465-475

1 reference

Epidemiology of restless legs symptoms in adults.

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Sex and the risk of restless legs syndrome in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless Legs Syndrome among working-aged women.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A questionnaire study of 138 patients with restless legs syndrome: the 'Night-Walkers' survey

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Arm restlessness in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Childhood-onset restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Symptoms of attention-deficit/hyperactivity disorder in adults with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

The Babinski response and periodic limb movement disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Recommendations for research into measurement and classification of sleep disordered breathing: gazing into the crystal ball.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

New actigraphic assessment method for periodic leg movements (PLM)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Iron, RLS and blood donations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Multiple blood donations associated with iron deficiency in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Clinical and biochemical findings in uremic patients with and without restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Long-term course of restless legs syndrome in dialysis patients after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Periodic limb movement disorder and restless legs syndrome in dialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Secondary periodic limb movement disorder and restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome and pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Subclinical sensory neuropathy in late-onset restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome: clinicoetiologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Mutational analysis of neurotensin in familial restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Autosomal dominant restless legs syndrome maps on chromosome 14q.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

The 14q restless legs syndrome locus in the French Canadian population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Analysis of CAG repeat expansions in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Sleep disturbance in spinocerebellar ataxias: is the SCA3 mutation a cause of restless legs syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Assessment of spontaneously occurring periodic limb movements in sleep in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Positron emission tomographic studies in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Functional neuroimaging studies in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Cerebral generators involved in the pathogenesis of the restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Abnormal H-reflexes in periodic limb movement disorder; impact on understanding the pathophysiology of the disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Idiopathic restless legs syndrome: abnormalities in central somatosensory processing

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs symptoms in a patient with above knee amputations: a case of phantom restless legs

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Iron status and restless legs syndrome in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Low body stores of iron and restless legs syndrome: a correctable cause of insomnia in adolescents and teenagers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

The treatment of restless legs syndrome with intravenous iron dextran

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

CSF iron, ferritin and transferrin levels in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

MRI measurement of brain iron in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Circadian rhythm of motor restlessness and sensory symptoms in the idiopathic restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Endocrine rhythms in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Circadian rhythm of restless legs syndrome: relationship with biological markers

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Augmentation of the restless legs syndrome with carbidopa/levodopa.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Pergolide in the management of restless legs syndrome: an extended study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Long-term effects of pergolide in the treatment of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Dopaminergic treatment of restless legs and rebound phenomenon.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

One‐year treatment with standard and sustained‐release levodopa: Appropriate long‐term treatment of restless legs syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A randomized controlled study of pergolide in patients with restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Effective cabergoline treatment in idiopathic restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Ropinirole for restless legs syndrome: a placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Ropinirole as a treatment of restless legs syndrome in patients on chronic hemodialysis: an open randomized crossover trial versus levodopa sustained release

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome improved by pramipexole: a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Pramipexole in the management of restless legs syndrome: an extended study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Treatment of restless legs syndrome with the dopamine agonist alpha-dihydroergocryptine.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Role of dopamine receptor agonists in the treatment of restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Long-term follow-up on restless legs syndrome patients treated with opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Gabapentin versus Ropinirole in the Treatment of Idiopathic Restless Legs Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Carbamazepine in restless legs. A controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Clonazepam and vibration in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD): acute placebo-controlled sleep laboratory studies with clonazepam

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Double-blind evaluation of clonazepam on periodic leg movements in sleep

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Nocturnal myoclonus: treatment efficacy of clonazepam and temazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

The use of triazolam in older patients with periodic leg movements, fragmented sleep, and daytime sleepiness.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

Effect of baclofen on sleep-related periodic leg movements.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2805%2970139-3

7 January 2021

10.1016/S1474-4422(05)70139-3

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16033689